10170 CHURCH RANCH WAY, WESTMINSTER, CO
Annual Meeting of Stockholders - Election of Class II Directors
First Amendment to IL-23 License Agreement with Paragon Therapeutics
Certain Financial and Operating Data for First Quarter
Reg. FD, Other Events
Annual Report to Security Holders
Director Resignation and Appointment at Oruka Therapeutics
Announces Positive Interim Phase 1 Results for ORKA-001
News, Material Contracts
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Notice of Proposed Sale of Securities
Prospectus filed pursuant to Rule 424(b)(7)